SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs >

PRA Health Sciences, Inc. (PRAH)

PRAH RSS Feed
Add PRAH Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 10/8/2016 1:06:58 PM - Followers: 0 - Board type: Free - Posts Today: 0
PRA Health Sciences, Inc.

4130 ParkLake Avenue
Suite 400
Raleigh, NC 27612
United States
919-786-8200

http://www.prahs.com

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development services to the biotechnology and pharmaceutical industries worldwide. The company offers integrated services, such as data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. Its services include a suite of product registration services, such as clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. The company’s services also comprise strategic solutions, including embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services, including Phase I through Phase IIa clinical trials and bioanalytical laboratory services. It conducts clinical trials in the areas of pharmaceutical development, comprising oncology, central nervous system, inflammation, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. The company was founded in 1976 and is headquartered in Raleigh, North Carolina. PRA Health Sciences, Inc. is a subsidiary of KKR PRA Investors L.P.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PRAH
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PRAH News: Statement of Changes in Beneficial Ownership (4) 11/18/2016 04:21:45 PM
PRAH News: Statement of Changes in Beneficial Ownership (4) 11/18/2016 04:20:54 PM
PRAH News: Current Report Filing (8-k) 11/16/2016 04:47:21 PM
PRAH News: Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) 11/15/2016 04:37:46 PM
PRAH News: Prospectus Filed Pursuant to Rule 424(b)(7) (424b7) 11/10/2016 05:25:10 PM
PostSubject
#1   PRAH bullish 57.20 stocktrademan 10/08/16 01:06:58 PM
PostSubject